Literature DB >> 15960680

Lactate is mainly fermented to butyrate by human intestinal microfloras but inter-individual variation is evident.

C Bourriaud1, R J Robins, L Martin, F Kozlowski, E Tenailleau, C Cherbut, C Michel.   

Abstract

AIM: To assess the role of lactate as a precursor for butyrate biosynthesis in human colonic microflora. METHODS AND
RESULTS: Three human faecal microfloras were incubated in vitro with media supplemented with 30 mmol l(-1) unenriched or 13C-enriched lactate. Lactate metabolism and short-chain fatty acid (SCFA) production were quantified. Lactate conversion to butyrate was investigated by gas chromatography-mass spectrometry and the pathways involved were identified by 13C nuclear magnetic resonance spectroscopy. All human faecal microfloras rapidly and completely fermented lactate, yielding approx. 19 mmol l(-1) total SCFAs. However, the SCFA composition varied markedly between microfloras. Butyrate was the main end-product for two microfloras but not for the third (60 and 61%vs 27% of the net concentration of SCFA produced respectively). The latter was typified by its ability to produce propionate as a major product (37%), and valerate (3%). 13C-Labelling showed that butyrate was produced through the acetyl-CoA pathway and that the three microfloras possessed significant differences in their metabolic pathways for lactate consumption.
CONCLUSIONS: In contrast to the ruminal microflora, the human intestinal microflora can utilize both d- and l-lactate as precursors for butyrate synthesis. Inter-individual variation is found. SIGNIFICANCE AND IMPACT OF THE STUDY: This study suggests that the butyrogenic capability of colonic prebiotics could be related to lactate availability. These findings will direct the development of selection strategies for the isolation of new butyrate-producing bacteria among the lactate-utilizing bacteria present in the human intestinal microfloras.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15960680     DOI: 10.1111/j.1365-2672.2005.02605.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  85 in total

1.  Reduced diversity and imbalance of fecal microbiota in patients with ulcerative colitis.

Authors:  Hideyuki Nemoto; Keiko Kataoka; Hideki Ishikawa; Kazue Ikata; Hideki Arimochi; Teruaki Iwasaki; Yoshinari Ohnishi; Tomomi Kuwahara; Koji Yasutomo
Journal:  Dig Dis Sci       Date:  2012-05-24       Impact factor: 3.199

Review 2.  The role of the gut microbiota in nutrition and health.

Authors:  Harry J Flint; Karen P Scott; Petra Louis; Sylvia H Duncan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-09-04       Impact factor: 46.802

3.  Use of stable isotopes to measure the metabolic activity of the human intestinal microbiota.

Authors:  Nicole Reichardt; Andrew R Barclay; Lawrence T Weaver; Douglas J Morrison
Journal:  Appl Environ Microbiol       Date:  2011-09-23       Impact factor: 4.792

Review 4.  Decoding molecular interactions in microbial communities.

Authors:  Nicole A Abreu; Michiko E Taga
Journal:  FEMS Microbiol Rev       Date:  2016-07-13       Impact factor: 16.408

5.  Feeding strategy shapes gut metagenomic enrichment and functional specialization in captive lemurs.

Authors:  E A McKenney; Thomas M O'Connell; Allen Rodrigo; Anne D Yoder
Journal:  Gut Microbes       Date:  2018-03-27

6.  Kinetic analysis of bifidobacterial metabolism reveals a minor role for succinic acid in the regeneration of NAD+ through its growth-associated production.

Authors:  Roel Van der Meulen; Tom Adriany; Kristof Verbrugghe; Luc De Vuyst
Journal:  Appl Environ Microbiol       Date:  2006-08       Impact factor: 4.792

7.  Impact of pH on lactate formation and utilization by human fecal microbial communities.

Authors:  Alvaro Belenguer; Sylvia H Duncan; Grietje Holtrop; Susan E Anderson; Gerald E Lobley; Harry J Flint
Journal:  Appl Environ Microbiol       Date:  2007-08-31       Impact factor: 4.792

8.  Phylogenetic distribution of three pathways for propionate production within the human gut microbiota.

Authors:  Nicole Reichardt; Sylvia H Duncan; Pauline Young; Alvaro Belenguer; Carol McWilliam Leitch; Karen P Scott; Harry J Flint; Petra Louis
Journal:  ISME J       Date:  2014-02-20       Impact factor: 10.302

9.  The impact of the level of the intestinal short chain Fatty acids in inflammatory bowel disease patients versus healthy subjects.

Authors:  N Huda-Faujan; A S Abdulamir; A B Fatimah; O Muhammad Anas; M Shuhaimi; A M Yazid; Y Y Loong
Journal:  Open Biochem J       Date:  2010-05-13

Review 10.  Whole grains, type 2 diabetes, coronary heart disease, and hypertension: links to the aleurone preferred over indigestible fiber.

Authors:  Stephen Lillioja; Andrew L Neal; Linda Tapsell; David R Jacobs
Journal:  Biofactors       Date:  2013-01-28       Impact factor: 6.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.